Nephrology Flashcards
Renal blood flow normally drains ___ of the cardiac output
~20%
The most common clinical course of contrast nephropathy is characterized by a rise in SCr beginning ____ following exposure, peaking within ____ , and resolving within
24–48 h
3–5 days
1 week
Definition of AKI
AKI is currently defined by a rise from baseline of at least 0.3 mg/dL within 48 h or at least 50% higher than baseline within 1 week, or a reduction in urine output to < 0.5 mL/kg per h for longer than 6 h.
Diseases that may present with eosinophilluria (5)
Allergic interstitial nephritis
Atheroembolic dse
Pyelonephritis
Cystitis
Glomerulonephritis
Diseases that may present with RBC casts (4)
Glomerulonephritis
Vasculitis
malignant Hypertension
Thrombotic Microangiopathy
Diseases that may present with WBC casts (5)
Interstitial Nephritis
Glomerulonephritis
Plyelonephritis
Allograft Rejection
Malignant Infiltration of the kidney
Diseases that may present with RTE casts (5)
ATN
Tubulointerstitial nephritis
Acute cellular allograft reaction
Myoglobulinuria
Hemoglobinuria
Diseases that may present with granular casts (4)
ATN
GN
Vasculitis
TIN
Diseases that may present with crystalluria
Acute uric acid nephropathy
Caox
Drugs or toxin (acyclovir, indinavir, sulfadiazin, amoxicillin)
Fe Na of pre renal AKI
< 1%
Dose for furosemide challenge
1-1.5 mg/kg
UO of ________ after IV furosemide may identify patients at higher risk of progression to more severe AKI, and the need for renal replacement therapy
< 200 mL over 2 h a
Molecule can be detected shortly after ischemic or nephrotoxic injury in the urine and, therefore, may be an easily tested biomarker in the clinical setting
KIM-1
_____ is highly upregulated after inflammation and kidney injury and can be detected in the plasma and urine within 2 h of cardiopulmonary bypass– associated
NGAL
patients with AKI should achieve a total energy intake of ____ kcal/kg per day.
20–30 kcal/kg per day
Protein intake in AKI
_____ g/kg in noncatabolic AKI without the need for dialysis;
_____ g/kg per day in patients on dialysis;
and up to a maximum of ____ per day if hypercatabolic and receiving continuous renal replacement therapy
0.8–1.0 g/kg per day
1.0–1.5 g/kg
1.7 g/kg
Alkali supplementation may attenuate the catabolic state and possibly slow CKD progression and is recommended when the serum bicarbonate concentration falls below ____ mmol/L.
20–23
These PTH FGFR3 changes start to occur when the GFR falls below ___ mL/min.
60 mL/min
_____ is a devastating condition seen almost exclusively in patients with advanced CKD. It is heralded by livedo reticularis and advances to patches of ischemic necrosis, especially on the legs, thighs, abdomen, and breasts
Calciphylaxis
Blood thinner that is considered a risk factor for calciphylaxis
Warfarin
Warfarin is commonly used in HD patients in whom most direct oral anticoagulants (DOACs) are contraindicated, and one of the effects of warfarin therapy is to decrease the vitamin K–dependent regeneration of matrix GLA protein which is important in preventing vascular calcification
Target PTH level for CKD
150 and 300 pg/mL
_______ is leading cause of morbidity and mortality in px at every stage of CKD
Cardiovascular disease
First line therapy for CKD to reduce BP
Salt restriction
In CKD patients with diabetes or proteinuria >1 g per 24 h, blood pressure should be reduced to ______ , if achievable without prohibitive adverse effects.
< 130/80 mmHg
normocytic, normochromic anemia is observed as early as stage ___ CKD and is almost universal by stage __
3,4
Target Hb for CKD
10-11.5 g/dl
Peripheral neuropathy usually becomes clinically evident after the patient reaches stage __ CKD, although electrophysiologic and histologic evidence occurs earlier.
4
P-eripheral neuropathy, P-or
Class of drugs that do not require dose reduction when EGFR is less than 50% of normal
SGLT 2 inhibitors
A skin condition unique to CKD patients called _____ consists of progressive subcutaneous induration, especially on the arms and legs.
nephrogenic fibrosing dermopathy
The condition is seen very rarely in patients with CKD who have been exposed to the magnetic resonance contrast agent gadolinium.
Current recommendations are that patients with CKD stage 3 (GFR 30–59 mL/min) should minimize exposure to gadolinium, and those with CKD stages 4–5 (GFR < 30 mL/min) should avoid the use of gadolinium agents unless it is medically necessary
Diseases where kidney size may be normal in the face of CKD (3)
diabetic nephropathy, amyloidosis, and HIV nephropathy
Discrepancy ___ cm in kidney length suggests either unilateral developmental abnormality or dse process or renovascular dse with arterial insufficiency affecting 1 kidney more than the other
> 1 cm
The most important complication of arteriovenous grafts is _______
thrombosis of the graft and graft failure
due principally to intimal hyperplasia at the anastomosis between the graft and recipient vein
_______ is the most common acute complication of hemodialysis, particularly among patients with diabetes mellitus.
Hypotension
Peritonitis in peritoneal dialysis is defined as _____
elevated peritoneal fluid leukocyte count (100/mm3 , of which at least 50% are polymorphonuclear neutrophils
_____ is the procedure of choice to rule out urinary obstruction or to confirm the presence of perirenal collections of urine, blood, or lymph.
Diagnostic ultrasound
The first rejection episode is usually treated with IV administration of
methylprednisolone, 500–1000 mg daily for 3 days.
Failure to respond is an indication for antibody therapy, usually with antithymocyte globulin.
Greater than ____mg/day of albuminuria represents frank proteinuria and more advanced renal disease
300 mg/24 h
___________ glomerulonephritis demonstrates hypercellularity of mesangial and endothelial cells, glomerular infiltrates of PMNs, granular subendothelial immune deposits of IgG, IgM, C3, C4 , and C5–9, and subepithelial deposits
PSGN
In PSGN In the first week of symptoms, ____ % of patients will have a depressed CH50 and decreased levels of C3 with normal levels of C4
90%
Treatment for PSGN
Treatment is supportive, with control of hypertension, edema, and dialysis as needed.
Antibodies that that fix complement correlate best with the presence of renal disease in lupus nephritis
Anti-dsDNA
Hypocomplementemia is common in patients with acute lupus nephritis (70–90%) and declining complement levels may herald a flare.
Class of Lupus nephritis that presents with mesangial hypercellularity with expansion of the mesangia matrix
Class II
Class of Lupus nephritis that presents with focal endocapillary and extracapillary proliferation with focal subendothelial immune deposits and mild mesangial expansion
Class III
Class of Lupus nephritis that presents with diffuse endocapillary and extracapillary proliferation with diffuse subendothelial immune deposits and mesangial alterations
Class IV
Class of Lupus nephritis that presents with thickened BM with diffuse subepithelial immune deposits
V
Class of lupus nephritis with Global sclerosis of nearly all glomerular capillaries
VI
Class of lupus nephritis with the most varied course
III
Henoch-Schönlein purpura is distinguished clinically from IgA nephropathy by (4).
prominent systemic ssx, a younger age (<20 years old), preceding infection, and abdominal complaints
Type I MPGN is associated with Hepatiti __ infection
C
Primary responders are patients who have a complete remission ( of____ proteinuria) after a single course of prednisone; steroid-dependent patients relapse as their steroid dose is tapered.
<0.2 mg/24 h
Response to steroids
Frequent relapsers have ____ relapses in ___ months following taper, and steroid-resistant patients fail to respond to steroid therapy.
two or more relapses in the 6 months
Adults are not considered steroid-resistant until after ___ months of therapy.
4
First line therapy for MCD
Prednisone
Treatment of patients with primary FSGS should include
inhibitors of the renin-angiotensin system
The treatment of secondary FSGS typically involves
treating the underlying cause and controlling proteinuria.
GN that has the highest reported incidences of renal vein thrombosis, pulmonary embolism, and deep-vein thrombosis.
MGN AKA membranous nephropathy
Therapy with immunosuppressive drugs is also recommended for patients with primary MGN and persistent proteinuria ____ g/day
(>3.0 g/24 h).
What microscopic finding is a sensitive indicator for the presence of diabetes but correlates poorly with the presence or absence of clinically significant nephropathy.
Thickening of the GBM
Microalbuminuria appears ____ years after the onset of diabetes.
5–10
More than ___% of patients with type 1 diabetes and nephropathy have diabetic retinopathy
90%
so the absence of retinopathy in type 1 patients with proteinuria should prompt consideration of a diagnosis other than diabetic nephropathy
There is a significant correlation between the presence of retinopathy and the presence of __________ nodules .
Kimmelstiel-Wilson
Characteristic lesion of HIVAN
The lesion in HIVAN is FSGS, characteristically revealing a collapsing glomerulopathy
Hydronephrosis may be absent on ultrasound when obstruction is less than ____ in duration or associated with volume contraction, staghorn calculi, retroperitoneal fibrosis, or infiltrative renal disease.
48 h